Newton, MA, United States of America

Yumei Sun

This inventor holds 1 USPTO granted patent. Top assignee: Aurora Biosciences Corporation. Active years: 2006.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yumei Sun. Retrieved from https://idiyas.com/inventor/yumei-sun

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2006

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Yumei Sun: Innovator in Signal Transduction Research

Introduction

Yumei Sun is a prominent inventor based in Newton, MA (US). She has made significant contributions to the field of signal transduction through her innovative research and patented inventions. Her work focuses on understanding the mechanisms of cellular signaling, which is crucial for developing new therapeutic strategies.

Latest Patents

Yumei Sun holds a patent titled "Compositions and methods for identifying modulators of transducisomes, a new class of therapeutic targets." This invention provides cells and methods for identifying modulators of signal transduction, based on transducisome proteins that coordinate and assemble various types of signal transduction proteins. A transducisome is defined as a PDZ domain containing protein that binds at least one signal transduction protein or a PDZ domain containing protein with at least one signal transduction protein bound. Examples of transducisome proteins include INAD, GRIP, and other recently identified multi-PDZ domain proteins. The patent also outlines methods for identifying modulators of signal transduction, proteins corresponding to transducisomes, modified transducisomes, or defective transducisomes for use in assays of signal transduction, and a screening assay system for detecting protein-protein interactions. Yumei Sun has 1 patent to her name.

Career Highlights

Yumei Sun is associated with Aurora Biosciences Corporation, where she continues to advance her research in signal transduction. Her work has implications for understanding various diseases and developing new therapeutic approaches.

Collaborations

Yumei has collaborated with notable scientists, including Charles S. Zuker and John D. Mendlein, enhancing the impact of her research through shared expertise and innovative ideas.

Conclusion

Yumei Sun's contributions to the field of signal transduction exemplify her dedication to scientific innovation. Her patented work on transducisomes opens new avenues for therapeutic development, showcasing her role as a leading inventor in this critical area of research.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…